Home > Insider Trading > Filing (0000899243-23-009990)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1521036	Lantheus Holdings Inc.	LNTH	In Vitro & In Vivo Diagnostic Substances (2835)	352318913

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1610676	Anne Mary Heino	C/O Lantheus Holdings, Inc. 201 Burlington Road, South Bldg Bedford MA 01730	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-03-27	44,484	$19.11	463,881	No	4	M	Indirect	Common Stock
Common Stock	Disposition	2023-03-27	28,662	$80.47	435,219	No	4	S	Indirect	Common Stock
Common Stock	Disposition	2023-03-27	15,822	$81.30	419,397	No	4	S	Indirect	Common Stock

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Indirect	Common Stock
No	4	S	Indirect	Common Stock
No	4	S	Indirect	Common Stock

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2023-03-27	44,484	$0.00	44,484	$19.11

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2023-04-15	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	300,000	Indirect	By Grantor Retained Annuity Trust

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023.
On March 10, 2023, the reporting person transferred 300,000 shares of LNTH common stock to a Grantor Retained Annuity Trust of which the reporting person's spouse is a trustee. The reporting person and members of her immediate family are the sole beneficiaries of the trust.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.89 to $80.88, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.89 to $81.838, inclusive. The reporting person undertakes to provide to LNTH any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
100% of the shares subject to the option are fully vested and exercisable.